DALBAVANCIN Pharmacologic Class Indexing
- Class set ID
- 80213c04-1008-4e56-bbd2-43f8065da5a1
- Version
- 3
- Effective date
- 20230503
- Type
- Indexing - Pharmacologic Class
Mapped DailyMed Labels#
Label, Manufacturer, Effective table| Label | Manufacturer | Effective | SPL version |
|---|
| These highlights do not include all the information needed to use DALBAVANCIN FOR INJECTION safely and effectively. See full prescribing information for DALBAVANCIN FOR INJECTION. DALBAVANCIN for injection, for intravenous use Initial U.S. Approval: 2014 | Fresenius Kabi USA, LLC | 20260402 | 2 |
| These highlights do not include all the information needed to use DALBAVANCIN FOR INJECTION safely and effectively. See full prescribing information for DALBAVANCIN FOR INJECTION. DALBAVANCIN for injection, for intravenous use Initial U.S. Approval: 2014 | Long Grove Pharmaceuticals, LLC | 20260217 | 2 |
| These highlights do not include all the information needed to use DALBAVANCIN FOR INJECTION safely and effectively. See full prescribing information for DALBAVANCIN FOR INJECTION . DALBAVANCIN for injection , for intravenous use Initial U.S. Approval: 2014 | Meitheal Pharmaceuticals Inc | Kindos Pharmaceuticals Co., Ltd. | 20251203 | 5 |
| These highlights do not include all the information needed to use DALBAVANCIN FOR INJECTION safely and effectively. See full prescribing information for DALBAVANCIN FOR INJECTION. DALBAVANCIN for injection, for intravenous use Initial U.S. Approval: 2014 | Teva Pharmaceuticals, Inc. | 20251006 | 3 |
| These highlights do not include all the information needed to use DALVANCE ® safely and effectively. See full prescribing information for DALVANCE . DALVANCE ( dalbavancin ) for injection , for intravenous use Initial U.S. Approval: 2014 | Allergan, Inc. | 20250113 | 29 |